Health lobbyists have told the government to ensure intellectual property will not be discussed when Kenya and the US resume trade talks next month.
They say intellectual property laws on patents lead to high prices of new medicines, restricting access.
Health lobbyists have told the government to ensure intellectual property will not be discussed when Kenya and the US resume trade talks next month.
Help us continue bringing you unbiased news, in-depth investigations, and diverse perspectives. Your subscription keeps our mission alive and empowers us to provide high-quality, trustworthy journalism. Join us today to make a difference!
